On August 2 2023, AMERISOURCEBERGEN CORPORATION ($NYSE:ABC) reported its earnings results for the quarter ended June 30 2023. Total revenue for the quarter rose 11.5% to USD 66947.0 million, while net income grew 17.8% year over year to USD 479.6 million.
On Wednesday, AMERISOURCEBERGEN CORPORATION released its earnings report for the third quarter of FY2023, showing encouraging results. The stock price of the company opened at $187.9 in the morning and closed at $191.4, which represented an increase of 1.2% from its previous closing price of 189.1. The strong earnings report from AMERISOURCEBERGEN CORPORATION seemed to have been well received by the markets, which is evidenced by the increase in its share price on Wednesday. Overall, the reports seem to have been positive for AMERISOURCEBERGEN CORPORATION investors and shareholders, as the company continues its trend of positive earnings results and increases in share price. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Amerisourcebergen Corporation. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Amerisourcebergen Corporation. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Amerisourcebergen Corporation. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Amerisourcebergen Corporation are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Analysis – Amerisourcebergen Corporation Intrinsic Value Calculation
We analyzed AMERISOURCEBERGEN CORPORATION‘s financials using GoodWhale’s proprietary valuation model. Our Valuation Line suggested an intrinsic value of around $155.8 per share. Currently, AMERISOURCEBERGEN CORPORATION’s stock is trading at $191.4, which is overvalued by 22.9%. This discrepancy between current market price and intrinsic value can be due to a variety of factors, such as investors’ sentiment or market dynamics. More…
Risk Rating Analysis
Star Chart Analysis
The AmerisourceBergen Corp is a healthcare services and distribution company. The company’s main competitors are Cardinal Health Inc, McKesson Corp, and Medipal Holdings Corp. AmerisourceBergen is the largest company in terms of revenue and market share. Cardinal Health is the second largest company, followed by McKesson.
– Cardinal Health Inc ($NYSE:CAH)
Cardinal Health Inc is a healthcare services and products company that operates in two segments: Pharmaceutical and Medical. The company’s Pharmaceutical segment provides customized pharmacy solutions, including contract packing, clinical services, and pharmacy software systems. The Medical segment provides a range of medical products, including surgical and medical gloves, needles and syringes, and medical and surgical supplies. Cardinal Health Inc has a market cap of 18.55B as of 2022, a Return on Equity of 55.12%. The company’s strong market position and financial stability has allowed it to maintain a strong ROE, even during periods of economic downturn.
McKesson is a large healthcare company that provides pharmaceuticals and medical supplies to hospitals, pharmacies, and other healthcare facilities. The company has a market cap of $51.84 billion and a return on equity of -74.43%. The company’s negative return on equity is due to its large debt load.
– Medipal Holdings Corp ($TSE:7459)
Paladin Labs Inc. is a Canadian pharmaceutical company that specializes in the development and marketing of prescription and over-the-counter products. In 2013, it was acquired by Hikma Pharmaceuticals PLC. The company has a market cap of 389.69B as of 2022 and a return on equity of 6.67%. Paladin’s products include treatments for conditions such as attention deficit hyperactivity disorder, pain, and cold and flu. The company also markets products for general health and wellness, such as vitamins and supplements.
Investors of AMERISOURCEBERGEN CORPORATION can be pleased with the company’s latest earnings report from its fiscal third quarter ended June 30, 2023. Total revenue for the quarter grew 11.5% year-over-year to USD 66947.0 million, while net income was up 17.8% to USD 479.6 million. This indicates a healthy performance by the company and signals potential for further growth in the future. Investors are advised to stay attuned to any further developments at AMERISOURCEBERGEN CORPORATION.